等待開盤 12-23 09:30:00 美东时间
-0.060
-1.76%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
Cantor Fitzgerald analyst Brett Knoblauch initiates coverage on Hyperliquid Strategies (NASDAQ:PURR) with a Overweight rating and announces Price Target of $5.
12-16 21:42
Hyperliquid Strategies Inc (NASDAQ:PURR) ("HSI" or the "Company") announced today that its Board of Directors has authorized a stock repurchase program of up to $30 million of the Company's outstanding common stock, par
12-08 22:21
Global Partner Acquisition Corp. - Units涨0.00%,最新市值0.50亿美元;Hyperliquid Strategies Inc. Ordinary Shares跌8.24%,最新市值12.28亿美元;Park Dental Partners跌21.15%,最新市值0.42亿美元;
12-04 06:00